ZANAMIVIR (RELENZA)
Zanamivir (Relenza); Antiviral, Neuraminidase Inhibitor; Diskhaler: 5 mg/inhalation; >7 yrs: 2 inhalations (total dose 10 mg) bid x 5 days
Approved for treatment of uncomplicated influenza type A or B in patients who have had symptoms for <48 hours. Risk of bronchospasm in patients
with asthma or chronic obstructive pulmonary disease.
Approved for treatment of uncomplicated influenza type A or B in patients who have had symptoms for <48 hours. Risk of bronchospasm in patients
with asthma or chronic obstructive pulmonary disease.